Cargando…

High Drug Resistance Prevalence among Vertically HIV-Infected Patients Transferred from Pediatric Care to Adult Units in Spain

BACKGROUND: Antiretroviral treatment (ART) has contributed to increased life expectancy of HIV-1 infected children. In developed countries, an increasing number of children reaching adulthood are transferred to adult units. The objectives were to describe the demographic and clinical features, ART h...

Descripción completa

Detalles Bibliográficos
Autores principales: de Mulder, Miguel, Yebra, Gonzalo, Navas, Adriana, de José, María Isabel, Gurbindo, María Dolores, González-Tomé, María Isabel, Mellado, María José, Saavedra-Lozano, Jesús, Muñoz-Fernández, María Ángeles, de Ory, Santiago Jiménez, Ramos, José Tomás, Holguín, África
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524105/
https://www.ncbi.nlm.nih.gov/pubmed/23284913
http://dx.doi.org/10.1371/journal.pone.0052155
_version_ 1782253272126455808
author de Mulder, Miguel
Yebra, Gonzalo
Navas, Adriana
de José, María Isabel
Gurbindo, María Dolores
González-Tomé, María Isabel
Mellado, María José
Saavedra-Lozano, Jesús
Muñoz-Fernández, María Ángeles
de Ory, Santiago Jiménez
Ramos, José Tomás
Holguín, África
author_facet de Mulder, Miguel
Yebra, Gonzalo
Navas, Adriana
de José, María Isabel
Gurbindo, María Dolores
González-Tomé, María Isabel
Mellado, María José
Saavedra-Lozano, Jesús
Muñoz-Fernández, María Ángeles
de Ory, Santiago Jiménez
Ramos, José Tomás
Holguín, África
author_sort de Mulder, Miguel
collection PubMed
description BACKGROUND: Antiretroviral treatment (ART) has contributed to increased life expectancy of HIV-1 infected children. In developed countries, an increasing number of children reaching adulthood are transferred to adult units. The objectives were to describe the demographic and clinical features, ART history, antiviral drug resistance and drug susceptibility in HIV-1 perinatally infected adolescents transferred to adult care units in Spain from the Madrid Cohort of HIV-1 infected children. METHODS: Clinical, virological and immunological features of HIV-1 vertically infected patients in the Madrid Cohort of HIV-infected children were analyzed at the time of transfer. Pol sequences from each patient were recovered before transfer. Resistance mutations according to the InternationaI AIDS Society 2011 list were identified and interpreted using the Stanford algorithm. Results were compared to the non-transferred HIV-1 infected pediatric cohort from Madrid. RESULTS: One hundred twelve infected patients were transferred to adult units between 1997 and 2011. They were mainly perinatally infected (93.7%), with a mean nadir CD4+-T-cells count of 10% and presented moderate or severe clinical symptoms (75%). By the time of transfer, the mean age was 18.9 years, the mean CD4+T-cells count was 627.5 cells/ml, 64.2% presented more than 350 CD4+T-cells/ml and 47.3% had ≤200 RNA-copies/ml. Most (97.3%) were ART experienced receiving Highly Active ART (HAART) (84.8%). Resistance prevalence among pretreated was 50.9%, 76.9% and 36.5% for Protease Inhibitors (PI), Nucleoside Reverse Transcriptase Inhibitors (NRTI) and Non-NRTI (NNRTI), respectively. Resistance mutations were significantly higher among transferred patients compared to non-transferred for the PI+NRTI combination (19% vs. 8.4%). Triple resistance was similar to non-transferred pediatric patients (17.3% vs. 17.6%). CONCLUSION: Despite a good immunological and virological control before transfer, we found high levels of resistance to PI, NRTI and triple drug resistance in HIV-1 infected adolescents transferred to adult units.
format Online
Article
Text
id pubmed-3524105
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35241052013-01-02 High Drug Resistance Prevalence among Vertically HIV-Infected Patients Transferred from Pediatric Care to Adult Units in Spain de Mulder, Miguel Yebra, Gonzalo Navas, Adriana de José, María Isabel Gurbindo, María Dolores González-Tomé, María Isabel Mellado, María José Saavedra-Lozano, Jesús Muñoz-Fernández, María Ángeles de Ory, Santiago Jiménez Ramos, José Tomás Holguín, África PLoS One Research Article BACKGROUND: Antiretroviral treatment (ART) has contributed to increased life expectancy of HIV-1 infected children. In developed countries, an increasing number of children reaching adulthood are transferred to adult units. The objectives were to describe the demographic and clinical features, ART history, antiviral drug resistance and drug susceptibility in HIV-1 perinatally infected adolescents transferred to adult care units in Spain from the Madrid Cohort of HIV-1 infected children. METHODS: Clinical, virological and immunological features of HIV-1 vertically infected patients in the Madrid Cohort of HIV-infected children were analyzed at the time of transfer. Pol sequences from each patient were recovered before transfer. Resistance mutations according to the InternationaI AIDS Society 2011 list were identified and interpreted using the Stanford algorithm. Results were compared to the non-transferred HIV-1 infected pediatric cohort from Madrid. RESULTS: One hundred twelve infected patients were transferred to adult units between 1997 and 2011. They were mainly perinatally infected (93.7%), with a mean nadir CD4+-T-cells count of 10% and presented moderate or severe clinical symptoms (75%). By the time of transfer, the mean age was 18.9 years, the mean CD4+T-cells count was 627.5 cells/ml, 64.2% presented more than 350 CD4+T-cells/ml and 47.3% had ≤200 RNA-copies/ml. Most (97.3%) were ART experienced receiving Highly Active ART (HAART) (84.8%). Resistance prevalence among pretreated was 50.9%, 76.9% and 36.5% for Protease Inhibitors (PI), Nucleoside Reverse Transcriptase Inhibitors (NRTI) and Non-NRTI (NNRTI), respectively. Resistance mutations were significantly higher among transferred patients compared to non-transferred for the PI+NRTI combination (19% vs. 8.4%). Triple resistance was similar to non-transferred pediatric patients (17.3% vs. 17.6%). CONCLUSION: Despite a good immunological and virological control before transfer, we found high levels of resistance to PI, NRTI and triple drug resistance in HIV-1 infected adolescents transferred to adult units. Public Library of Science 2012-12-17 /pmc/articles/PMC3524105/ /pubmed/23284913 http://dx.doi.org/10.1371/journal.pone.0052155 Text en © 2012 de Mulder et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
de Mulder, Miguel
Yebra, Gonzalo
Navas, Adriana
de José, María Isabel
Gurbindo, María Dolores
González-Tomé, María Isabel
Mellado, María José
Saavedra-Lozano, Jesús
Muñoz-Fernández, María Ángeles
de Ory, Santiago Jiménez
Ramos, José Tomás
Holguín, África
High Drug Resistance Prevalence among Vertically HIV-Infected Patients Transferred from Pediatric Care to Adult Units in Spain
title High Drug Resistance Prevalence among Vertically HIV-Infected Patients Transferred from Pediatric Care to Adult Units in Spain
title_full High Drug Resistance Prevalence among Vertically HIV-Infected Patients Transferred from Pediatric Care to Adult Units in Spain
title_fullStr High Drug Resistance Prevalence among Vertically HIV-Infected Patients Transferred from Pediatric Care to Adult Units in Spain
title_full_unstemmed High Drug Resistance Prevalence among Vertically HIV-Infected Patients Transferred from Pediatric Care to Adult Units in Spain
title_short High Drug Resistance Prevalence among Vertically HIV-Infected Patients Transferred from Pediatric Care to Adult Units in Spain
title_sort high drug resistance prevalence among vertically hiv-infected patients transferred from pediatric care to adult units in spain
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524105/
https://www.ncbi.nlm.nih.gov/pubmed/23284913
http://dx.doi.org/10.1371/journal.pone.0052155
work_keys_str_mv AT demuldermiguel highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT yebragonzalo highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT navasadriana highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT dejosemariaisabel highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT gurbindomariadolores highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT gonzaleztomemariaisabel highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT melladomariajose highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT saavedralozanojesus highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT munozfernandezmariaangeles highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT deorysantiagojimenez highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT ramosjosetomas highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT holguinafrica highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain
AT highdrugresistanceprevalenceamongverticallyhivinfectedpatientstransferredfrompediatriccaretoadultunitsinspain